Impact of diagnosis and treatment on response to COVID-19 vaccine in patients with BCR-ABL1-negative myeloproliferative neoplasms. A single-center experience

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Blood cancer journal (New York) 2021-11, Vol.11 (11), p.185-185, Article 185
Hauptverfasser:	Cattaneo, Daniele, Bucelli, Cristina, Cavallaro, Francesca, Consonni, Dario, Iurlo, Alessandra
Format:	Artikel
Sprache:	eng
Schlagworte:	692/699/1541/1990/2331 692/700/459/1748 Adult Aged Aged, 80 and over Biomedical and Life Sciences Biomedicine Cancer Research Correspondence COVID-19 - genetics COVID-19 - immunology COVID-19 - prevention & control COVID-19 - virology COVID-19 Vaccines - therapeutic use Female Fusion Proteins, bcr-abl - genetics Hematology Humans Male Middle Aged Myeloproliferative Disorders - diagnosis Myeloproliferative Disorders - drug therapy Myeloproliferative Disorders - immunology Myeloproliferative Disorders - virology Oncology SARS-CoV-2 - immunology SARS-CoV-2 - isolation & purification
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!